AminoAnalytica
YC S24London, GB · Founded 2024 · 3 employees · 1 known investors
Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
AI & Machine LearningBiotechHealthtechMedical DevicesNanosensorsSynthetic BiologyDiagnosticsTherapeuticsin /aminoanalytica/@aminoanalytica
Founders & leadership· Y Combinator alumni (S24)
Investors · 1
In the news
- Amina: The Agentic Protein Engineerycombinator.com · 2025
- AminoAnalytica Funding | $750K Revenue | Complete Analysis | Extruct AIextruct.ai · 2025
- AminoAnalytica - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2025
- 🧬 AminoAnalytica – Next generation proteins engineered with *protein* language modelsycombinator.com · 2024